Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis Connie M. Rhee, MD, MSc, Csaba P. Kovesdy,

Slides:

Advertisements

Similar presentations

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Outcomes Associated With Microalbuminuria: Effect.

Advertisements

Date of download: 6/25/2016 From: Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study Ann Intern Med. 2013;159(4):

2016 Annual Data Report, Vol 1, CKD, Ch 8

Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J

Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD

Association Between Serum Leptin Level and Mortality in Kidney Transplant Recipients Miklos Z. Molnar, MD, PhD, FEBTM, FERA, FASN, Kristof Nagy, MD, Adam.

Chronic Kidney Disease in Diabetes

Mortality rates in incident ESRD patients figure 9

Kamyar Kalantar-Zadeh, Connie M. Rhee, Jason Chou, S

The Relationship Between Ultraviolet Light Exposure and Mortality in Dialysis Patients Am J Nephrol 2014;40: DOI: / Fig. 1. Association.

Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index Suma Vupputuri, PhD, Caroline.

Body Mass Index and All-cause Mortality in Chronic Kidney Disease: A Dose–response Meta-analysis of Observational Studies Mehran Rahimlu, MSc, Sakineh.

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and.

Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease Connie M. Rhee, MD, MSc, Kamyar Kalantar-Zadeh, MD, MPH, PhD, Vanessa Ravel,

Revisiting Interdialytic Weight Gain and Mortality Association With Serum Albumin Interactions: The Japanese Dialysis Outcomes and Practice Pattern Study

Is it Important to Prevent and Treat Protein-Energy Wasting in Chronic Kidney Disease and Chronic Dialysis Patients? Bereket Tessema Lodebo, MD, MPH,

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients Jiacong Luo, MD, MS, MPH, Donna E.

Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,

Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,

Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey Orlando M. Gutiérrez, MD, MMSc, Tamara.

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Association of Relatively Low Serum Parathyroid Hormone With Malnutrition- Inflammation Complex and Survival in Maintenance Hemodialysis Patients Ramanath.

Novel Equations for Estimating Lean Body Mass in Patients With Chronic Kidney Disease Xue Tian, MD, Yuan Chen, BN, Zhi-Kai Yang, MD, PhD, Zhen Qu, MD,

The US Renal Data System “Pie Chart of Death”

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

Cardiovascular Disease and CKD: Core Curriculum 2010

Chronic Kidney Disease in Diabetes

Determinants of Plasma Adiponectin Levels in Nondiabetic Subjects With Moderate to Severe Chronic Kidney Disease Luis F. Ramos, MD, Ayumi Shintani, PhD,

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)

Volume 64, Issue 3, Pages (September 2003)

Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP) Richard.

Volume 86, Issue 4, Pages (October 2014)

Your Kidneys May Outlive You

Volume 88, Issue 2, Pages (August 2015)

Glycemic Management in ESRD and Earlier Stages of CKD

Normalization of Protein Intake by Body Weight and the Associations of Protein Intake With Nutritional Status and Survival Srinivasan Beddhu, MD, Nirupama.

Molly E. Waring, PhD, Jane S

Volume 79, Pages S9-S13 (April 2011)

Guidelines for the Older Adult With CKD

Yang Liu, MPH, Marie Fanelli Kuczmarski, PhD, Edgar R

Let Them Eat During Dialysis: An Overlooked Opportunity to Improve Outcomes in Maintenance Hemodialysis Patients Kamyar Kalantar-Zadeh, MD, MPH, PhD,

Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.

Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.

The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population Claudine T. Jurkovitz, MD, MPH, Yang Qiu,

Volume 84, Issue 4, Pages (October 2013)

Body Mass Index, Coronary Artery Calcification, and Kidney Function Decline in Stage 3 to 5 Chronic Kidney Disease Patients Jocelyn S. Garland, MD, Rachel.

Volume 84, Issue 5, Pages (November 2013)

Management of Heart Failure in Advancing CKD: Core Curriculum 2018

Volume 86, Issue 4, Pages (October 2014)

Physical Activity Dose for Hemodialysis Patients: Where to Begin

CKD and the Risk of Acute, Community-Acquired Infections Among Older People With Diabetes Mellitus: A Retrospective Cohort Study Using Electronic Health.

Volume 77, Issue 7, Pages (April 2010)

Volume 80, Issue 2, Pages (July 2011)

U-shaped effect of eGFR and mortality

Volume 83, Issue 4, Pages (April 2013)

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States George A. Kaysen, MD, PhD, Kirsten.

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease C.P. Kovesdy, S. Ahmadzadeh,

Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD

Volume 82, Issue 3, Pages (August 2012)

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes Steven M. Brunelli, Ravi Thadhani,

Potential Impact of Nutritional Intervention on End-Stage Renal Disease Hospitalization, Death, and Treatment Costs Eduardo Lacson, MD, T. Alp Ikizler,

Friends, social networks, and progressive chronic kidney disease

Jacob J.E. Koopman, MD, PhD American Journal of Kidney Diseases

Presentation transcript:

Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis Connie M. Rhee, MD, MSc, Csaba P. Kovesdy, MD, Vanessa A. Ravel, MPH, Elani Streja, MPH, PhD, John J. Sim, MD, Amy S. You, MS, Justin Gatwood, MPH, PhD, Alpesh N. Amin, MD, MBA, Miklos Z. Molnar, MD, PhD, Danh V. Nguyen, MS, PhD, Kamyar Kalantar- Zadeh, MD, MPH, PhD Journal of Renal Nutrition Volume 29, Issue 2, Pages 82-90 (March 2019) DOI: 10.1053/j.jrn.2018.07.003 Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Study cohort creation for averaged random glucose analyses (A) and HbA1c analyses (B). CKD, chronic kidney disease; CV, cardiovascular; ESRD, end-stage renal disease; HbA1c, hemoglobin A1c. Journal of Renal Nutrition 2019 29, 82-90DOI: (10.1053/j.jrn.2018.07.003) Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Association of averaged random glucose and mortality in the Transition Cohort (A) versus Nontransition Cohort (B). HR, hazard ratio; CI, confidence interval. Journal of Renal Nutrition 2019 29, 82-90DOI: (10.1053/j.jrn.2018.07.003) Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Spline analyses of averaged random glucose and mortality in the Transition Cohort (A) versus Nontransition Cohort (B). Transition Cohort analyses adjusted for expanded case-mix + laboratory covariates, which included patient's calendar quarter of dialysis initiation, age, sex, race, ethnicity, cause of ESRD, CCI score, diabetes, CHF, CVD, residential region, initial dialysis modality, body mass index, serum albumin, hemoglobin, serum bicarbonate, eGFR averaged over the 1-year prelude period, and last eGFR level measured prior to dialysis initiation. Nontransition Cohort analyses adjusted for expanded case-mix + laboratory covariates, which included patient's study entry quarter, age, sex, race, ethnicity, CCI score, diabetes, CHF, CVD, residential region, body mass index, serum albumin, hemoglobin, serum bicarbonate, and eGFR levels. CCI, Charlson Comorbidity Index; CHF, congestive heart failure; CVD, cerebrovascular disease; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease. Journal of Renal Nutrition 2019 29, 82-90DOI: (10.1053/j.jrn.2018.07.003) Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

Figure 4 Spline analyses of HbA1c and mortality in the Transition Cohort (A) versus Nontransition Cohort (B). Transition Cohort analyses adjusted for expanded case-mix + laboratory covariates, which included patient's calendar quarter of dialysis initiation, age, sex, race, ethnicity, cause of ESRD, CCI score, diabetes, CHF, CVD, residential region, initial dialysis modality, body mass index, serum albumin, hemoglobin, serum bicarbonate, eGFR averaged over the 1-year prelude period, and last eGFR level measured before dialysis initiation. Nontransition Cohort analyses adjusted for expanded case-mix + laboratory covariates, which included patient's study entry quarter, age, sex, race, ethnicity, CCI score, diabetes, CHF, CVD, residential region, body mass index, serum albumin, hemoglobin, serum bicarbonate, and eGFR levels. CCI, Charlson Comorbidity Index; CHF, congestive heart failure; CVD, cerebrovascular disease; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; HbA1c, hemoglobin A1c. Journal of Renal Nutrition 2019 29, 82-90DOI: (10.1053/j.jrn.2018.07.003) Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions